Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2575 of 2873 entries
View as:

Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients

Phase: N/A Priority: Normal
NCT ID: NCT00412243 Org: User:
Start: 03/31/06 End: 04/30/12 Due: 04/30/13

Phase II Study of ZD6474 in Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT00290537 Org: User:
Start: 01/31/06 End: 04/30/08 Due: 04/30/09

Adaptation of the American Cancer Society (ACS) Early Detection of Prostate Cancer Patient Decision Aid for Spanish Speaking Men

Phase: N/A Priority: Normal
NCT ID: NCT01447186 Org: User:
Start: 09/21/12 End: 01/13/15 Due: 01/13/16

Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT04132440 Org: User:
Start: 08/22/19 End: 05/01/30 Due: 05/01/31

Physician Perceptions About Parenteral Hydration in Latin America and Spain

Phase: N/A Priority: Normal
NCT ID: NCT01011140 Org: User:
Start: 01/31/10 End: 01/31/20 Due: 01/31/21

Utility of Vancomycin Loading: A Pharmacokinetic Analysis in Critically Ill Patients

Phase: N/A Priority: Normal
NCT ID: NCT01157533 Org: User:
Start: 06/30/10 End: 01/31/12 Due: 01/31/13

Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial, An Umbrella Protocol

Phase: N/A Priority: Normal
NCT ID: NCT00851032 Org: User:
Start: 02/28/09 End: 02/28/21 Due: 02/28/22

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Phase: N/A Priority: Normal
NCT ID: NCT00378781 Org: User:
Start: - End: - Due: -

Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05904782 Org: User:
Start: 11/01/25 End: 11/01/27 Due: 11/01/28

Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)

Phase: N/A Priority: Normal
NCT ID: NCT00542971 Org: User:
Start: 10/31/07 End: 05/31/11 Due: 05/31/12

Role of Diet on the Microbiome of the Digestive System

Phase: N/A Priority: Normal
NCT ID: NCT04666727 Org: User:
Start: 09/29/20 End: 01/01/26 Due: 01/01/27

Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04734990 Org: User:
Start: 07/07/21 End: 09/11/25 Due: 09/11/26

Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Activated Signaling Pathway Mutations

Phase: N/A Priority: Normal
NCT ID: NCT07032727 Org: User:
Start: 12/03/25 End: 06/01/29 Due: 06/01/30

Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT05039632 Org: User:
Start: 05/08/23 End: 02/01/26 Due: 02/01/27

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03630991 Org: User:
Start: 10/11/18 End: 04/30/27 Due: 04/30/28

Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT00529230 Org: User:
Start: 12/11/01 End: 02/19/04 Due: 02/19/05

Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00317720 Org: User:
Start: 04/30/06 End: 02/28/13 Due: 02/28/14

Role of Spirituality in Coping and Surviving With Ovarian Cancer, Primary Peritoneal or Fallopian Tube Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00499512 Org: User:
Start: 08/10/05 End: 08/31/20 Due: 08/31/21

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03077841 Org: User:
Start: 03/06/17 End: 11/08/27 Due: 11/08/28

Identification of Surgical Management of Lymph Node Basins and Surgical Practice Patterns Among Sarcoma Surgeons

Phase: N/A Priority: Normal
NCT ID: NCT04553744 Org: User:
Start: 06/22/20 End: 02/26/24 Due: 02/26/25

Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis

Phase: N/A Priority: Normal
NCT ID: NCT00491855 Org: User:
Start: 06/30/07 End: 12/31/12 Due: 12/31/13

Lenalidomide in Treating Patients With High Risk Acute Myeloid Leukemia in Remission

Phase: N/A Priority: Normal
NCT ID: NCT02126553 Org: User:
Start: 11/13/14 End: 11/30/21 Due: 11/30/22

Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT01515527 Org: User:
Start: 02/07/12 End: 02/01/26 Due: 02/01/27

Harmony & Health: A Culturally Adapted Mindbody Intervention to Reduce Sitting Time and Improve Psychosocial Wellbeing in Black Adults

Phase: N/A Priority: Normal
NCT ID: NCT05922943 Org: User:
Start: 08/14/24 End: 06/30/29 Due: 06/30/30

Pembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02500576 Org: User:
Start: 08/07/15 End: 10/12/22 Due: 10/12/23